CC
BOLD

Carlson Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History

Carlson Capital’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-480,901
Closed -$28.8M – 326
2019
Q4 		$28.8M Buy
+480,901
New +$18M 0.52% 64

Carlson Capital's BOLD Position: Q1 2020 in Review

Carlson Capital sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 480,901 shares — an estimated $28.8M sold.

Carlson Capital first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $28.8M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Carlson Capital reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Carlson Capital sold 480,901 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $28.8M.
  • Carlson Capital first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Carlson Capital's Audentes Therapeutics, Inc position peaked at $28.8M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Carlson Capital's 13F filing for Q1 2020, filed 14 May 2020.